HOME > About Us > Our History

  • About Us
  • Our Missions & Visions
  • Message from President
  • Our Overview
  • Our History
  • Our Network
  • Access
  • Link

About Us

About Us



Jul 2018

Daiwa held the “BioBran International Workshop in 2018” in Kyoto, Japan

Mar 2017

Daiwa was awarded with “Rising Small and Medium Enterprises 300 in 2017”

Jul 2016

Daiwa was selected for Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

Sep 2014

Daiwa was selected for Subsidy from the Kanto Bureau of Economy, Trade and Industry for the Development of Functional Food Ingredient

Apr 2014

Daiwa held the “BioBran International Workshop 2014” in Tokyo, Japan.

Feb 2014

Daiwa obtained a patent for BioBran as an agent for bowel disease treatment.

Oct 2013

Daiwa was selected for Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

Jun 2013

Daiwa was authorized as “The Project Based on Collaboration of Primary, Secondary, and Tertiary Industry Act” by the Ministry of Agriculture, Forestry and Fisheries

Jan 2013

Daiwa held the “NKCP Workshop 2013” in Tokyo, Japan.

Jul 2012

Global sales of BioBran spread to 50 countries.

Jul 2011

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in USA.

May 2011

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Hong Kong.

Apr 2011

Daiwa launched “Kefira Plus”, a new product from “LK500” and “Kefira”.

Jan 2011

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in China.

Aug 2010

Daiwa held the “BioBran Workshop 2010” in Tokyo, Japan.

Dec 2009

Global sales of NKCP spread to 20 countries.

Oct 2009

Daiwa obtained a patent (cancer distant metastasis-suppressing agent) for NKCP in Japan.
Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Switzerland, Germany, France and UK.

Aug 2009

Daiwa held the “BioBran International Workshop 2009” in Tokyo, Japan.

May 2009

Daiwa obtained a patent (Diabetes drug) for NKCP in Japan.

Apr 2008

Daiwa launched Rice Kefiran-based products, “LK500” and “Kefira”.

Aug 2007

Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Taiwan.

Apr 2007

Global sales of BioBran spread to 40 countries.
Daiwa obtained a patent (Blood-viscosity reducing agent) for NKCP in Korea.

Jun 2006

Daiwa held a meeting to launch “Rice Kefiran”, a new vegetable-origin functional food ingredient, in Tokyo, Japan.
Daiwa began export of Rice Kefiran.

May 2006

Daiwa held BioBran book publication seminar in Tokyo, Japan.

May 2005

Daiwa launched new BioBran-based products, “Lentin Plus LY” and “BioBran Candy”.

Sep 2004

Daiwa established overseas affiliated company, Daiwa Health Development Inc., in Los Angeles, CA., U.S.A.

Apr 2004

Daiwa obtained a process patent for NKCP in Japan.

Mar 2004

Daiwa held International Seminar, “2004 General Meeting of BioBran Study Conference”, in Tokyo, Japan.
Daiwa obtained a process patent for BioBran in Japan.

Dec 2003

Tsukuba Plant obtained HACCP certification.

Jul 2003

Daiwa obtained approval from the Ministry of Health, Labor, and Welfare to label “PIOTEA Drink Powder” as a food for specified health use.

Jun 2003

Daiwa established overseas affiliated company, SIAM DHD, in Bangkok, Thailand.

Mar 2003

Daiwa completed expansion of the Tsukuba Plant.

Dec 2002

Daiwa obtained ISO9001 certification.

Apr 2002

Global sales of BioBran spread to 27 countries.

Nov 2001

Daiwa began export of NKCP.

Apr 2001

Daiwa obtained approval from the Ministry of Health, Labor, and Welfare to label “PIOTEA Drink” and “PIOTEA Roasted Powder” as a food for specified health use.
Daiwa launched a NKCP-based product, “NKCP tablet”.

Feb 2001

Daiwa held the “BioBran Study Conference 2001” in Tsukuba, Japan.

Sep 2000

Daiwa established overseas affiliated company, DHD (Europe) Ltd, in Cambridge, U.K.

Aug 2000

Daiwa commenced research and development of Rice Kefiran, with sponsorship from the Ministry of Agriculture, Forestry, and Fisheries of Japan.

Mar 2000

Daiwa opened the Tsukuba Plant.

Oct 1999

Daiwa began export of BioBran to the United States.

May 1998

Daiwa commenced research and development of Purified Natto Culture Filtrate (NKCP).

Jul 1997

Daiwa obtained a process patent for BioBran in 8 countries, including the U.S.

Sep 1996

Daiwa began export of BioBran to both Korea and Taiwan.

Apr 1996

Daiwa opened the Kakegawa Plant.
Daiwa launched a BioBran-based product, “Lentin Plus 1000”.

Mar 1995

Daiwa established the extraction technology of a new physiologically active substance, “MGN-3” (Rice Bran Arabinoxylan Compound), in rice bran.

Apr 1992

Daiwa commenced development in the area of functional foods.
Daiwa began a cooperative study with Professor Mamdooh Ghoneum of UCLA/Drew University of Medicine and Science.

Feb 1990

Daiwa Pharmaceutical Co., Ltd. was founded.
Daiwa began export of pharmaceuticals.